Product Details
Osimertinib for Tablets BP
Product Name
:
Osimertinib for Tablets BP
Brand Name
:
VEROSIM
Available Strength
:
80 mg
Packing
:
30 Tablets
Pack Insert/Leaflet
:
According To Your Needs
These film-coated tablets meet British Pharmacopoeia standards, supporting targeted treatment for EGFR-mutated non-small cell lung cancer. Oncologists prescribe Osimertinib for patients whose tumors test positive for specific EGFR mutations, including those resistant to earlier-generation EGFR inhibitors.
Osimertinib BP (equivalent to Osimertinib 80 mg) is a third-generation tyrosine kinase inhibitor that selectively targets EGFR mutations, interrupting the growth pathway driving these tumors while sparing wild-type EGFR. As a result, it helps control tumor progression in eligible patients, including those with brain metastases. Because of this targeted mechanism, oncology specialists prescribe it under close supervision as part of an individualized treatment plan. Therefore, hospitals and oncology clinics restrict its use to patients under specialist care.
Key Features
- Meets BP (British Pharmacopoeia) standards for consistent quality
- Delivers selective, third-generation EGFR inhibition for lung cancer therapy
- Ensures accurate, validated dosing in every batch
- Manufactured under GMP-compliant, high-alert medication handling protocols
- Intended strictly for use under oncologist supervision
- Restricted to hospital, oncology clinic, and specialist institutional supply